Diffuse Large B-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Diffuse Large B-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-02-03Clinical Trial Update: Selumetinib in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma [Phase 2]
A Phase 2 trial of selumetinib for relapsed or refractory diffuse large B-cell lymphoma has been terminated, with results posted.
-
CLINICAL_TRIALS research · 2016-01-28Clinical Trial Update: Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by CART19 [NA]
Clinical trial update describing CART19 therapy for relapsed and/or chemotherapy-refractory B-cell malignancies with an unknown status of th…
-
CLINICAL_TRIALS trial_result · 2016-01-08Clinical Trial Update: MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma [Phase 1]
Phase 1 trial update for MORAb-004 in young patients with recurrent or refractory solid tumors or lymphoma; the study has been completed.
-
CLINICAL_TRIALS withdrawal · 2016-01-06Clinical Trial Update: A Phase Ib Study of Belinostat With RDHAP Chemotherapy (Dexamethasone, Cytarabine, Cisplatinum) in Adults With Relapsed or Refractory Diffuse Large B-cell Lymphoma [Phase 1]
The trial, a Phase Ib study of belinostat with RDHAP chemotherapy for relapsed or refractory diffuse large B-cell lymphoma, has been withdra…
-
CLINICAL_TRIALS research · 2015-12-30Clinical Trial Update: Treatment of Diffuse Large B Cell Lymphoma [Phase 4]
Clinical trial update for a Phase 4 treatment of Diffuse Large B Cell Lymphoma. The trial status is currently unknown.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-12-14Clinical Trial Update: Efficacy of Consolidative Involved-site Radiotherapy for Patients With Limited-stage Diffuse Large B-cell Lymphoma [Phase 3]
Phase 3 clinical trial evaluating consolidative involved-site radiotherapy for patients with limited-stage diffuse large B-cell lymphoma; st…
-
CLINICAL_TRIALS trial_result · 2015-12-14Clinical Trial Update: The Palliative Benefit of Involved-site Radiotherapy for Patients With Advanced-stage Diffuse Large B-cell Lymphoma [Phase 3]
This document provides an update on a Phase 3 clinical trial evaluating the palliative benefit of involved-site radiotherapy for patients wi…
-
CLINICAL_TRIALS research · 2015-12-11Clinical Trial Update: A Study of Improving the Efficacy of Treatment in Diffused Large B Cell Lymphoma Patients
A clinical trial update concerning improving treatment efficacy for diffuse large B-cell lymphoma; no status or results are provided in the …
-
CLINICAL_TRIALS trial_result · 2015-12-04Clinical Trial Update: Obatoclax and Bortezomib in Treating Patients With Aggressive Relapsed or Recurrent Non-Hodgkin Lymphoma [Phase 1]
Phase 1 trial of obatoclax with bortezomib in adults with aggressive relapsed or recurrent non-Hodgkin lymphoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-11-26Clinical Trial Update: Lenalidomide And Rituximab as Maintenance Therapy in Treating Patients With B-Cell Non-Hodgkin Lymphoma [Phase 1]
Phase 1 trial of lenalidomide plus rituximab as maintenance therapy for adult B-cell non-Hodgkin lymphoma is noted as terminated.
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Study of Repeat Intranodal Injections of Ad-ISF35 [Phase 2]
Phase 2 study of repeat intranodal injections of Ad-ISF35 in various non-Hodgkin lymphomas was terminated; results were posted in 2015.
-
CLINICAL_TRIALS research · 2015-11-18Clinical Trial Update: R-CHOP Versus R-CDOP as First-line Treatment for Elderly Patients With Diffuse Large-B-cell Lymphoma [Phase 3]
This Phase 3 clinical trial compares R-CHOP with R-CDOP as first-line therapy in elderly patients with diffuse large B-cell lymphoma.
-
CLINICAL_TRIALS trial_result · 2015-11-13Clinical Trial Update: Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies [Phase 2]
Phase 2 study evaluating a triple regimen of vorinostat, tacrolimus, and methotrexate to prevent graft-versus-host disease after allogeneic …
-
CLINICAL_TRIALS research · 2015-09-29Clinical Trial Update: Genetically Engineered Lymphocyte Therapy in Treating Patients With Lymphoma That is Resistant or Refractory to Chemotherapy [Phase 1, Phase 2]
Clinical trial update describing a Phase 1/Phase 2 study of a genetically engineered lymphocyte therapy for chemotherapy-resistant or refrac…
-
CLINICAL_TRIALS trial_result · 2015-09-04Clinical Trial Update: Study of YM155 in Refractory Diffuse Large B-cell Lymphoma (DLBCL) Subjects [Phase 2]
Phase 2 trial of YM-155 for refractory diffuse large B-cell lymphoma was terminated.
-
CLINICAL_TRIALS trial_result · 2015-09-03Clinical Trial Update: Sorafenib Tosylate in Treating Patients With Recurrent Aggressive Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating sorafenib tosylate in patients with recurrent aggressive non-Hodgkin lymphomas has completed, with results posted i…
-
CLINICAL_TRIALS trial_result · 2015-09-02Clinical Trial Update: Rituximab, Gemcitabine and Oxaliplatin (R-GEMOX) for Refractory/Relapsed B-cell Lymphoma [Phase 2]
Phase 2 trial results for R-GEMOX (rituximab, gemcitabine, oxaliplatin) in refractory/relapsed B-cell lymphoma, including diffuse large B-ce…
-
CLINICAL_TRIALS trial_result · 2015-09-02Clinical Trial Update: R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-cell Lymphoma [Phase 3]
Phase 3 trial comparing R-CHOP-14 versus R-CHOP-21 with Darbepoetin alfa in patients aged 60-80 with diffuse large B-cell lymphoma has compl…
-
CLINICAL_TRIALS trial_result · 2015-09-02Clinical Trial Update: ACVBP Plus Rituximab in Patients Aged From 18 to 59 Years With High-risk Diffuse Large B-cell Lymphoma [Phase 2]
This update reports the completion of a Phase 2 trial evaluating ACVBP plus Rituximab in adults aged 18 to 59 with high-risk diffuse large B…
-
CLINICAL_TRIALS research · 2015-08-25Clinical Trial Update: High-dose Chemotherapy and ASCT or Consolidating Conventional Chemotherapy in Primary CNS Lymphoma [Phase 3]
A Phase 3 clinical trial comparing high-dose chemotherapy with autologous stem cell transplantation to consolidating conventional chemothera…
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic Malignancies [Phase 1]
Phase 1 study evaluating the combination of methoxyamine and fludarabine phosphate in adults with relapsed or refractory hematologic maligna…
-
CLINICAL_TRIALS trial_result · 2015-07-27Clinical Trial Update: Clinical Study With Blinatumomab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) [Phase 2]
Phase 2 clinical trial evaluating blinatumomab in relapsed/refractory diffuse large B-cell lymphoma has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2015-07-02Clinical Trial Update: Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery [Phase 1]
Phase 1 study sponsored by the National Cancer Institute evaluating dasatinib in patients with metastatic or unresectable solid tumors and l…
-
CLINICAL_TRIALS trial_result · 2015-07-01Clinical Trial Update: MGCD0103 Administered in Combination With Azacitidine (Vidaza®) to Subjects With Relapsed or Refractory Hodgkin or Non-Hodgkin Lymphoma [Phase 2]
A Phase 2 trial of MGCD0103 in combination with azacitidine (Vidaza) for relapsed or refractory Hodgkin lymphoma and non-Hodgkin lymphoma ha…
-
CLINICAL_TRIALS trial_result · 2015-06-26Clinical Trial Update: Study of Infusion of Blood Cells (Lymphocytes) to Stimulate the Immune System to Fight Leukemia/Lymphoma [Phase 2]
A Phase 2 trial evaluating infusion of blood cells (lymphocytes) to stimulate the immune system for fighting leukemia/lymphoma was terminate…